Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

First head-to-head comparison of leading valve types finds better valve performance with selfexpanding valve and non-inferior clinical outcomes at one year

News | Cardiovascular Clinical Studies

Self-Expanding Valve Outperforms Balloon-Expandable Valve for TAVR in Patients with Small Valve Annulus

April 9, 2024 — People with a small aortic annulus, a part of the heart’s anatomy where the left ventricle meets the ...

April 09, 2024

Infusions reduce lead levels but show no effect on clinical endpoints

News | Cardiovascular Clinical Studies

Chelation Therapy Does Not Improve Outcomes after Heart Attack

April 8, 2024 — People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium ...

April 08, 2024

$Study suggests routine use is likely unnecessary for those with normal ejection fraction$

News | Cardiovascular Clinical Studies

Beta Blockers May Not Benefit Many Heart Attack Survivors

April 8, 2024 — Taking beta blockers after a heart attack did not significantly reduce the risk of death or a second ...

April 08, 2024

Mechanical circulatory support boosts survival in cardiogenic shock patients, despite risks

News | Cardiovascular Clinical Studies

Heart Pump Improves Survival After Severe Heart Attacks

April 8, 2024 — Implantation of the Impella CP micro-axial flow pump in the hours after a heart attack significantly ...

April 08, 2024

Earning points or small sums of money encourages people to ‘step up’ their physical activity

News | Cardiovascular Clinical Studies

Incentives Prompt Increased Daily Walking in Patients at Risk for Heart Disease

April 7, 2024 — Strategies such as earning points or small amounts of money encouraged people at high risk for heart ...

April 07, 2024

When added to standard blood pressure medication, new drug could minimize the need for pills and reduce cardiovascular risks

News | Cardiovascular Clinical Studies

One Injection of Novel Drug Cuts Systolic Blood Pressure by Up to 12 mmHg

April 7. 2024 — A single subcutaneous injection of the investigational drug zilebesiran, when added to existing ...

April 07, 2024

$Study shows no benefit for heart failure overall but suggests different effects in those with preserved versus reduced ejection fraction$

News | Cardiovascular Clinical Studies

RELIEVE-HF Trial Outcomes Reported at ACC.24 Find Impact of Interatrial Shunt May Vary by Heart Failure Type

April 6, 2024 — Patients with heart failure who had a small shunt inserted between the heart’s left and right atria did ...

April 06, 2024

While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack

News | Cardiovascular Clinical Studies

EMPACT-MI Trial Outcomes Reported at ACC.24: SGLT-2 Inhibitors Show Mixed Results After Heart Attack

April 6, 2024 — Use of the sodium glucose cotransporter-2 (SGLT-2) inhibitor empagliflozin following a heart attack did ...

April 06, 2024

Registration is open for a leading conference on structural heart disease announced by the Cardiovascular Research Foundation, CRF.

News | Cardiovascular Business

Cardiovascular Research Foundation, CRF, Introduces New York Valves: The Structural Heart Summit

April 5, 2024 — The Cardiovascular Research Foundation (CRF) has announced New York Valves: The Structural Heart Summit ...

April 05, 2024

The acquisition enhances Johnson and Johnson’s ability to transform the treatment landscape for cardiovascular disease and continue to improve patient outcomes

News | Cardiovascular Business

Johnson and Johnson to Acquire Shockwave Medical

April 5, 2024 — Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive ...

April 05, 2024

Virtual Reality Simulation Company Collaborates with American College of Cardiology to Help Cardiovascular Clinicians Immersively Practice Clinical Procedures

News | Left Atrial Appendage (LAA) Occluders

Osso VR Expands Cardiology Training through ACC Collaboration

April 4, 2024 — Osso VR, a leader in immersive procedural training, announces the release of a co-developed curriculum ...

April 04, 2024

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

News | Balloon Catheter

FDA Announces Medos International Sàrl Recall of Cerenovus CEREBASE DA Guide Sheath due to Cracking of the Distal Catheter Shaft

April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sàrl is recalling Cerenov ...

April 04, 2024

Here is a look at the most-read content during the month of March on dicardiology.com

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Top 10: What Viewers Were Reading in March

Here is a Top 10 look at the content that was trending during the month of March on dicardiology.com:

1. CLS Health ...

April 04, 2024

In gearing up for its Annual Scientific Session, ACC.24, amidst the 75th anniversary of the organization, the American College of Cardiology (ACC) has planned a full range of educational programming, special events and peer networking scheduled throughout the April 6-8 event in Atlanta, GA.

Feature | ACC | Christine Book

American College of Cardiology Sets Full Range of Education Sessions and Meetings ACC Scientific Session, ACC.24

April 3, 2024 — In gearing up for its Annual Scientific Session, ACC.24, amidst the 75th anniversary of the organization ...

April 03, 2024

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries, serious health consequences, or death

News | Catheters

FDA Announces Teleflex and Arrow International Recall of ARROW QuickFlash Radial Artery and Radial Artery/Arterial Line Catheterization Kits for Increased Resistance That May Lead to Vessel Injuries, Narrowing, or Blockage

April 3, 2024 — The U.S. Food and Drug Administration (FDA) announced that Teleflex and Arrow International are ...

April 03, 2024